Peripha Gen
Pharmaceuticals, 2100 Wharton St, Pittsburgh, Pennsylvania, 15203, United States, 1-10 Employees
Phone Number: 41********
Who is PERIPHAGEN
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders th...
Read More
-
Headquarters: 2100 Wharton St, Pittsburgh, Pennsylvania, 15203, United States
-
Date Founded: 2012
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from PERIPHAGEN
PeriphaGen Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PeriphaGen
Answer: PeriphaGen's headquarters are located at 2100 Wharton St, Pittsburgh, Pennsylvania, 15203, United States
Answer: PeriphaGen's phone number is 41********
Answer: PeriphaGen's official website is https://periphagen.com
Answer: PeriphaGen's revenue is Under $1 Million
Answer: PeriphaGen's SIC: 8731
Answer: PeriphaGen has 1-10 employees
Answer: PeriphaGen is in Pharmaceuticals
Answer: PeriphaGen contact info: Phone number: 41******** Website: https://periphagen.com
Answer: PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life. We believe that the best way to treat the nervous system diseases is to directly target neurons. Our proprietary Neuronal Therapeutics (NET) platform can express gene constructs in discrete regions of the nervous system following a simple intradermal injection, allowing for unparalleled treatment specificity and substantially reduced systemic adverse effects. Our lead product, PGN-503, is focused on protecting against Chemotherapy Induced Peripheral Neuropathy (CIPN), the leading dose-limiting side effect observed in the majority of antineoplastic drugs. Our pipeline also includes the treatment of chronic pain by NET drugs designed to block multiple pain pathways through the expression of various gene combinations.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month